Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation
NCT: NCT05090540 · ENROLLING_BY_INVITATION
Brief Summary
The mechanical intervention is treating secondary mitral regurgitation (SMR) which may be performed using the standard open surgical approach or transcatheter edge to edge repair (TEER). The key question of this study is to establish the difference in left ventricular reverse remodeling after adjustment for death, as assessed by means of the left ventricular end-systolic dimension(LVESD), all-cause and cause-specific (cardiac vs noncardiac) mortality in patients who received the TEER vs the standard surgical procedure for SMR.
Frequently Asked Questions
What is Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation?
Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation is a clinical trial registered under NCT05090540. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT05090540?
The current status of NCT05090540 (Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation) is: ENROLLING_BY_INVITATION.
When did Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation start?
Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation started on 2017-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.